Sign In
Buy ESPR
$3.14
+0 (+0%)
At Close: Jun 03, 2026
Esperion, Otsuka Pharmaceutical sign deal for NEXLETOL, NEXLIZET in Japan ESPR
11:23am, Monday, 20'th Apr 2020
Esperion, Otsuka Pharmaceutical sign deal for NEXLETOL, NEXLIZET in Japan ESPR
Esperion (ESPR) today announced that they have entered into a collaboration agreement with Otsuka Pharmaceutical Co., Ltd. for the development and commercialization of NEXLETOL and NEXLIZET tablets in
JMP Reiterates $191 Price Target On Esperion After Japan Partnership
12:00am, Monday, 20'th Apr 2020Were Hedge Funds Right About Sunrun Inc (RUN)?
03:09pm, Saturday, 18'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Were Hedge Funds Right About Eagle Bancorp, Inc. (EGBN)?
03:08pm, Saturday, 18'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Were Hedge Funds Right About Gibraltar Industries Inc (ROCK)?
03:00pm, Saturday, 18'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Were Hedge Funds Right About Selling Esperion Therapeutics (ESPR)?
02:59pm, Saturday, 18'th Apr 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
Nuveen Asset Management LLC Lowers Stock Holdings in Esperion Therapeutics Inc (NASDAQ:ESPR)
09:50am, Saturday, 18'th Apr 2020
Nuveen Asset Management LLC trimmed its stake in Esperion Therapeutics Inc (NASDAQ:ESPR) by 43.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchang
Bailard Inc. Has $2.94 Million Stock Holdings in Esperion Therapeutics Inc (NASDAQ:ESPR)
09:44am, Friday, 17'th Apr 2020
Bailard Inc. grew its holdings in Esperion Therapeutics Inc (NASDAQ:ESPR) by 393.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
Northland Capital Markets Maintains Market Perform on Esperion Therapeutics, Lowers Price Target to $42
04:57pm, Thursday, 16'th Apr 2020Esperion price target lowered to $42 from $60 at Northland ESPR
01:21pm, Thursday, 16'th Apr 2020
Esperion price target lowered to $42 from $60 at Northland Northland ESPR
Northland Securities Keeps a Hold Rating on Esperion (ESPR)
11:06am, Thursday, 16'th Apr 2020
Northland Securities analyst Carl Byrnes maintained a Hold rating on Esperion (ESPR) today and set a price target of $42.00. The company's shares closed
Northland Securities Keeps a Hold Rating on Esperion (ESPR)
11:06am, Thursday, 16'th Apr 2020
Northland Securities analyst
Carl Byrnes
maintained a
Hold
rating on Esperion (
ESPR
–
Research Report
) today and set a price target of
$42.00
. The company’s shares closed last Wednesday at $34.
Esperion management to meet virtually with JMP Securities ESPR
03:41pm, Wednesday, 15'th Apr 2020
Esperion management to meet virtually with JMP Securities ESPR
